Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.

<h4>Background</h4>Vitamin K-antagonists (VKA) are treatment of choice and standard care for patients with venous thrombosis and thromboembolic risk. In experimental animal models as well as humans, VKA have been shown to promote medial elastocalcinosis. As vascular calcification is cons...

Full description

Saved in:

Bibliographic Details
Main Authors:	Leon J Schurgers, Ivo A Joosen, Eduard M Laufer, Martijn L L Chatrou, Marjolein Herfs, Mark H M Winkens, Ralf Westenfeld, Verena Veulemans, Thilo Krueger, Catherine M Shanahan, Willi Jahnen-Dechent, Erik Biessen, Jagat Narula, Cees Vermeer, Leonard Hofstra, Chris P Reutelingsperger
Format:	article
Language:	EN
Published:	Public Library of Science (PLoS) 2012
Subjects:	Medicine R Science Q
Online Access:	https://doaj.org/article/073113b23a7543c09f9b7724adf5511a
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/073113b23a7543c09f9b7724adf5511a

Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.

Internet

Similar Items